Published on 21/12/2025
‘ICH-GCP Requirements for Sponsors’
Introduction
The International Council for Harmonization (ICH) Guideline for Good Clinical Practice (GCP) is an international standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials. It provides assurance that the data reported are credible and accurate and that the rights, integrity, and confidentiality of trial subjects are protected. One critical aspect of the ICH-GCP guidelines is the obligations of the sponsor. This article aims to outline these responsibilities in detail.
Quality Assurance and Quality Control
The sponsor is responsible for implementing and maintaining quality assurance and quality control systems with written SOPs (Standard Operating Procedures) to ensure that trials are conducted and data are generated, documented, and reported in compliance with the protocol, GCP, and the applicable regulatory requirements. Sponsors can find more information on Pharma SOPs, SOP validation in pharma, and the pharmaceutical process validation on Pharma SOPs and Pharma Validation.
Protocol Design and Trial Management
The sponsor is also required to design a scientifically sound protocol, manage the trial, and arrange for the investigator’s/institution’s agreement to conduct the trial and abide by the protocol. The sponsor is also tasked with
Data Handling and Record Keeping
Another critical obligation of the sponsor is data handling and record keeping. The sponsor should ensure the accuracy, completeness, legibility, and timeliness of the data reported to them by the investigators. The sponsor is also responsible for the secure handling of all personal data and should take steps to prevent accidental or premature destruction of these data. For more details about data handling and records, you can check out Drug approval process by FDA and Pharma regulatory submissions.
Confirmation of Review of Data
The sponsor should obtain confirmation from each investigator or institution that the investigator has completed the review and verification of the trial data. This step is essential to ensure that all data is accurate and has undergone a thorough review process.
Stability of Test Products
The sponsor should ensure the stability of the test investigational product(s). They should base assignments of storage conditions for the investigational products on acceptable scientific data. For more information on stability testing and stability studies, you can refer to Stability testing and Stability Studies.
Adherence to Regulatory Authorities
Lastly, the sponsor must adhere to all the regulatory requirements of the applicable regulatory authority(ies). They must ensure compliance with the aspects of the local regulations under the purview of these authorities. For UK-based sponsors, for instance, the MHRA would be the relevant regulatory authority.
Conclusion
In conclusion, the sponsor has a wide range of responsibilities under the ICH-GCP guidelines. These responsibilities are essential to ensure the credibility and reliability of the trial data and the protection of the rights, safety, and well-being of the study participants. Fulfillment of these obligations is a prerequisite for the scientific and ethical conduct of clinical trials.